Myriad Asset Management’s NEVRO CORP. NVRO Stock Holding History

Myriad Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-272,500	Closed	-$21.8M	–	83
2018 Q2	$21.8M	Hold	272,500	–	–	3.02%	11
2018 Q1	$23.6M	Hold	272,500	–	–	2.11%	14
2017 Q4	$18.8M	Sell	272,500 -10,000	-4%	-$800K	1.86%	13
2017 Q3	$25.7M	Sell	282,500 -48,100	-15%	-$4.12M	2.49%	9
2017 Q2	$24.6M	Buy	+330,600	New	+$26.5M	1.72%	14
2016 Q3	–	Sell	-14,900	Closed	-$1.1M	–	62
2016 Q2	$1.1M	Buy	+14,900	New	+$1.01M	0.1%	44

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Myriad Asset Management's NVRO Position: Q3 2018 in Review

Myriad Asset Management sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 272,500 shares — an estimated $21.8M sold.

Myriad Asset Management first reported a position in NVRO in Q2 2016 and held it in 6 quarters. The position peaked at $25.7M in Q3 2017. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

Myriad Asset Management reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
Myriad Asset Management sold 272,500 NEVRO CORP. shares in Q3 2018, an estimated $21.8M.
Myriad Asset Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 6 quarters.
Myriad Asset Management's NEVRO CORP. position peaked at $25.7M in Q3 2017.
171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Myriad Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.